Breast cancer pharmacogenomics: where we are going

ISSN： 1462-2416

Source： Pharmacogenomics, Vol.13, Iss.6, 2012-04, pp. : 629-631

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Tuberculosis: where are we going?

By Thwaites Guy

Clinical Medicine, Vol. 6, Iss. 6, 2006-12 ,pp. : 523-525

Royal College Of Physicians

Access to resources Recommend Favorite

Hormone-Refractory Prostate Cancer: Where are We Going?

By Giuseppe Di Lorenzo

Drugs, Vol. 67, Iss. 8, 2007-01 ,pp. : 1109-1124

Adis International

Access to resources Recommend Favorite

Chronic lymphocytic leukemia: where are we and where are we going?

By Ujjani Chaitra Cheson Bruce D

Expert Opinion on Pharmacotherapy, Vol. 13, Iss. 12, 2012-08 ,pp. : 1675-1677

Informa Healthcare

Access to resources Recommend Favorite

Pharmacokinetic adaptation of 5-fluorouracil: where are we and where are we going?

By Boisdron-Celle Michèle

Pharmacogenomics, Vol. 13, Iss. 13, 2012-10 ,pp. : 1437-1439

Future Medicine

Access to resources Recommend Favorite

Genomics and Pharmacogenomics in the Management of Breast Cancer

Current Pharmacogenomics and Personalized Medicine (Formerly Current Pharmacogenomics), Vol. 6, Iss. 1, 2008-03 ,pp. : 45-55

Bentham Science Publishers

Access to resources Recommend Favorite